Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies
Based on the success of tumor-infiltrating lymphocytes (TIL)-based therapies, personalized adoptive cell therapies (ACT) targeting neoantigens have the potential to become a disruptive technology and lead to highly effective treatments for cancer patients for whom no other options exist. ACT of TIL,...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2021-01-01
|
| Serija: | OncoImmunology |
| Teme: | |
| Online pristup: | http://dx.doi.org/10.1080/2162402X.2020.1869389 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|